STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." Trademark
Trademark Overview
On Monday, December 1, 2025, a trademark application was filed for STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." with the United States Patent and Trademark Office. The USPTO has given the STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." trademark a serial number of 99522920. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, May 22, 2026. This trademark is owned by STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC. The STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Consulting services for others in the field of design, planning, and implementation project management of clinical research and trials, namely, clinical research development plans, clinical trial design and execution, ethical review board assistance and review, and clinical heath risk mitigation strategies
General Information
| Serial Number | 99522920 |
| Word Mark | STRATAGENIC CLINICAL TRIAL SOLUTIONS "WHERE INNOVATION BEGINS WITH INTENTION." |
| Filing Date | Monday, December 1, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, May 22, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "CLINICAL TRIAL SOLUTIONS" |
| Pseudo Mark | STRATAGENIC CLINICAL TRIAL SOLUTIONS WHERE INNOVATION BEGINS WITH INTENTION |
| Description of Mark | The mark consists of an image of 4 connected diamonds placed in a manner to comprise a larger single diamond. Underneath is the word STRATAGENIC in a large bold font and below in a smaller, less bold font is CLINICAL TRIAL SOLUTIONS and at the bottom in italics, and in a much smaller non-bold font is "WHERE INNOVATION BEGINS WITH INTENTION.". |
| Goods and Services | Consulting services for others in the field of design, planning, and implementation project management of clinical research and trials, namely, clinical research development plans, clinical trial design and execution, ethical review board assistance and review, and clinical heath risk mitigation strategies |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 1, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 24, 2025 |
| First Use In Commerce Date | Friday, October 24, 2025 |
Trademark Owner History
| Party Name | STRATAGENIC CLINICAL TRIAL SOLUTIONS LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Templeton, MA 01468
US |
Trademark Events
| Event Date | Event Description |
| Monday, December 1, 2025 | NEW APPLICATION ENTERED |
| Monday, December 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 27, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 27, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, April 2, 2026 | ASSIGNED TO EXAMINER |
| Monday, April 13, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, April 13, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, April 13, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 22, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 22, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 22, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
